European Heart Journal Advance Access originally published online on November 10, 2006
European Heart Journal 2006 27(23):2833-2839; doi:10.1093/eurheartj/ehl358
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis
1 Department of Cardiology, VU University Medical Center, De Boelelaan 1117, PO Box 7057, 1081 HV Amsterdam, The Netherlands
2 Department of Physics and Medical Technology, VU University Medical Center, Amsterdam, The Netherlands
3 Department of Cardiology, Thoraxcenter Erasmus Medical Center, Rotterdam, The Netherlands
4 Department of Cardiology, St Antonius Hospital, Nieuwegein, The Netherlands
5 Department of Clinical Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands
Received 1 March 2006; revised 12 October 2006; accepted 19 October 2006; online publish-ahead-of-print 10 November 2006.
* Corresponding author. Tel: +31 20 4442244; fax: +31 20 4442446. E-mail address: wg.vandockum{at}vumc.nl
See page 2746 for the editorial comment on this article (doi:10.1093/eurheartj/ehl324)
Aims Alcohol septal ablation (ASA) has been successful in the treatment of symptomatic hypertrophic obstructive cardiomyopathy (HOCM). The aim of this study is to evaluate the effects of ethanol-induced myocardial infarcts on regional myocardial function using cardiac magnetic resonance (CMR) tissue tagging and 3-dimensional (3D) strain analysis.
Methods and results In nine patients (age 52±15 years) who underwent ASA, CMR was performed prior to and 6 months after the procedure. Regional myocardial mass was evaluated using cine imaging. Myocardial tagging was used to calculate systolic 3D myocardial strain values. These strain values were used to calculate the shortening index (SI), a robust parameter for myocardial contraction. Maximum end-systolic (ES) SI and systolic SI rate were quantified in three circumferential segments: septum, adjacent, and remote (lateral) myocardium. Compared with baseline, septal and non-septal mass decreased at follow-up (from 72±27 to 59±21 g; P=0.008 and from 131±34 to 109±30 g; P=0.008, respectively). In the septum, maximum ES SI and SI rate remained unchanged after ASA. In adjacent myocardium, ES SI remained unchanged, whereas SI rate improved (from 56.5±21.1 to 70.0±16.7%/s; P=0.02). Both ES SI and SI rate improved significantly in remote myocardium (from 16.9±2.8 to 18.8±3.2%; P=0.02 and from 70.3±9.2 to 86.1±15.0%/s; P=0.01, respectively).
Conclusion Reduction of left ventricular (LV) outflow tract obstruction in symptomatic HOCM is associated with a significant reduction in myocardial mass and improvement of intramural systolic function in the lateral (remote) wall, indicating reversed LV remodelling.
Key Words: Hypertrophy Cardiomyopathy Myocardial ablation Tagging Magnetic resonance imaging
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Can alcohol septal ablation normalize systolic function in HOCM?
- Hisham Dokainish and Nasser Lakkis
EHJ 2006 27: 2746-2747.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
J. Wang, J. M. Buergler, K. Veerasamy, Y. P. Ashton, and S. F. Nagueh Delayed untwisting: the mechanistic link between dynamic obstruction and exercise tolerance in patients with hypertrophic obstructive cardiomyopathy. J. Am. Coll. Cardiol., September 29, 2009; 54(14): 1326 - 1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Alam, H. Dokainish, and N. M. Lakkis Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis Eur. Heart J., May 1, 2009; 30(9): 1080 - 1087. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Fifer Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy Circulation, July 10, 2007; 116(2): 207 - 216. [Full Text] [PDF] |
||||
![]() |
G. K. Efthimiadis, N. E. Mezilis, G. Giannakoulas, and G. E. Parcharidis Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar Eur. Heart J., May 2, 2007; 28(10): 1270 - 1271. [Full Text] [PDF] |
||||
![]() |
W. G. van Dockum, M. J.W. Gotte, P. Knaapen, and A. C. van Rossum Septal alcohol ablation in hypertrophic obstructive cardiomyopathy: improving cardiac function by generating a myocardial scar Eur. Heart J., May 2, 2007; 28(10): 1271 - 1271. [Full Text] [PDF] |
||||
![]() |
H. Dokainish and N. Lakkis Can alcohol septal ablation normalize systolic function in HOCM? Eur. Heart J., December 1, 2006; 27(23): 2746 - 2747. [Full Text] [PDF] |
||||


